Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus - Replacement

23 Jun 2017 11:00

RNS Number : 0163J
Reckitt Benckiser Group PLC
23 June 2017
 



The following replaces the announcement released at 17:26 on 22 June 2017 under RNS number 9498I.

The announcement is being re-released to include a link to a PDF document.

Publication of Offering Memorandum

 

23 June 2017

RECKITT BENCKISER

Publication of Offering Memorandum

 

The offering memorandum dated 22 June 2017 (the "Offering Memorandum") in relation to the issue by Reckitt Benckiser Treasury Services plc ("RBTS") of US$7.75 billion aggregate principal amount of senior notes in four tranches, consisting of US$750 million Floating Rate Senior Notes due 2022 (the "Floating Rate Notes"), US$2.5 billion Fixed Rate Senior Notes due 2022 (the "2022 Fixed Rate Notes"), US$2.0 billion Fixed Rate Senior Notes due 2024 (the "2024 Fixed Rate Notes") and US$2.5 billion Fixed Rate Senior Notes due 2027 (the "2027 Fixed Rate Notes" and, together with the Floating Rate Notes, the 2022 Fixed Rate Notes and the 2024 Fixed Rate Notes, the "Notes"), each fully and unconditionally guaranteed by Reckitt Benckiser Group plc ("RB") (LSE: RB.), has been approved by the UK Listing Authority and is available for viewing.

To view the full document, paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/0163J_1-2017-6-23.pdf

A copy of the Offering Memorandum and the documents incorporated by reference therein have been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other security and shall not constitute an offer, solicitation or sale in the United States or to U.S. persons (as defined in Regulation S under the Securities Act ("Regulation S")) or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful.

The Notes and the guarantees have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and, subject to certain exceptions, may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S). The Notes are being offered and sold outside the United States only to non-U.S. persons in reliance on Regulation S and within the United States to "qualified institutional buyers" in reliance on Rule 144A under the Securities Act ("Rule 144A"). Prospective purchasers of the Notes are hereby notified that the seller may be relying on the exemption from the provisions of Section 5 of the Securities Act provided by Rule 144A.

For further information, contact:

RB: +44 1753 217800

Richard Joyce- SVP, Investor Relations

Patty O'Hayer - Director, External Relations and Government Affairs

 

Brunswick: +44 (0)20 7404 5959

Gabrielle Silver / David Litterick

 

Further information

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

Disclaimer - intended addressees

Please note that the information contained in the Offering Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Offering Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Offering Memorandum is not addressed. Prior to relying on the information contained in the Offering Memorandum, you must ascertain from the Offering Memorandum whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

Important notice

This announcement is not for release, publication or distribution directly or indirectly, in whole or in part, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. This announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIUOVKRBVANURR
Date   Source Headline
9th Apr 202010:00 amRNSDirectorate Change
6th Apr 202011:42 amRNSAnnual Financial Report
3rd Apr 202010:31 amRNSDirector Declaration
1st Apr 202011:26 amRNSTotal Voting Rights
24th Mar 20204:57 pmRNSDirector/PDMR Shareholding
24th Mar 20204:41 pmRNSSecond Price Monitoring Extn
24th Mar 20204:35 pmRNSPrice Monitoring Extension
12th Mar 20205:08 pmRNSDirector/PDMR Shareholding
9th Mar 20204:45 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:26 pmRNSDirector/PDMR Shareholding
2nd Mar 20201:11 pmRNSTotal Voting Rights
27th Feb 20207:00 amRNSFull Year Results 2019
3rd Feb 202011:16 amRNSTotal Voting Rights
2nd Jan 202012:20 pmRNSTotal Voting Rights
4th Dec 20191:30 pmRNSDirectorate Change
2nd Dec 201912:00 pmRNSTotal Voting Rights
1st Nov 201912:00 pmRNSTotal Voting Rights
29th Oct 20194:30 pmRNSDirector/PDMR Shareholding
28th Oct 201911:21 amRNSDirector/PDMR Shareholding
24th Oct 20192:30 pmRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSQ3 2019 Trading Update
21st Oct 201910:15 amRNSDirectorate Change
1st Oct 201911:51 amRNSTotal Voting Rights
30th Sep 20193:12 pmRNSDirector/PDMR Shareholding
18th Sep 201912:00 pmRNSDirectorate Change
3rd Sep 20191:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20191:00 pmRNSDirectorate Change
2nd Sep 201912:37 pmRNSTotal Voting Rights
30th Aug 20193:00 pmRNSDirector/PDMR Shareholding
6th Aug 20192:07 pmRNSDirector/PDMR Shareholding
1st Aug 20199:48 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSHalf Year Results 2019
29th Jul 20199:30 amRNSDirectorate Change
11th Jul 20197:00 amRNSAgreement to resolve all federal investigations
1st Jul 201911:31 amRNSTotal Voting Rights
12th Jun 20197:00 amRNSRB CEO Announcement
3rd Jun 201910:49 amRNSTotal Voting Rights
28th May 201910:40 amRNSDirector/PDMR Shareholding
23rd May 20194:40 pmRNSDirector/PDMR Shareholding
22nd May 201911:45 amRNSDirector/PDMR Shareholding
13th May 20193:01 pmRNSDirector/PDMR Shareholding
9th May 20193:28 pmRNSResult of AGM
2nd May 20197:00 amRNSQ1 Trading Update
1st May 201910:46 amRNSDirectorate Change
1st May 20199:00 amRNSTotal Voting Rights
10th Apr 201910:37 amRNSUS Justice Department indictment of Indivior Plc
4th Apr 201912:45 pmRNSDirector Declaration
2nd Apr 20194:56 pmRNSAnnual Financial Report
1st Apr 20199:30 amRNSTotal Voting Rights
27th Mar 20192:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.